Speakers

Expand/Collapse

Aruna Rajan
Founder & CEO
Arogyam

Workshop Day

2:00 pm | Actionable Business Insights from the Analytics of the Microbiome

2:30 pm | Panel Discussion: Building a Brand Around the Consumer & Expanding Your Target Population

Emma Taylor
CEO & Co-Founder
Naked Biome

Day One

Thursday 13th December 2018

4:30 pm | Effectively Designing & Undertaking Clinical Trials in a Cost Effective Manner

11:30 am | Panel Discussion: Exploring to What Extent Staphylococcus Bacterium are Driving Inflammatory Skin Disease

Nathan Brown
Co-Founder
Parallel

Day Two

Thursday 13th December 2018

2:00 pm | Exploring How Bacteriophages Can Impact the Skin Microbiome

Eric Huang
Professor
University of California

Day Two

Thursday 13th December 2018

10:30 am | Exploring Probiotics on the Skin Microbiome

Dan Brownell
Director, R&D
AOBiome

Day One

Thursday 13th December 2018

9:30 am | Using Ammonia Oxidizing Bacteria to Treat Inflammatory Skin Disease

Jessica O’Connell
Partner
Covington & Burling LLP

Day Two

Thursday 13th December 2018

12:15 pm | Assessing Claim Substantiation: Regulatory & Legal Perspective

Nicole Scott
CEO & Founder
Cybele Microbiome

Nicole is a domain expert in the microbiome and data science with more than 20 years of experience, with the last 6 years in startups doing everything from marketing, business strategy, IP, data analysis, and fundraising. She studied at the University of Michigan and University of Chicago with Dr. Jack Gilbert, and was the first employee at Dr. Rob Knight’s microbiome startup Biota. She is cited more than 2000 times, published in prestigious journals such as Science and Nature, and is the author of several book chapters and patents. She also serves as an advisor to several other startups in biotech.

Day Two

Thursday 13th December 2018

3:30 pm | Panel Discussion - The Borderline Between Therapy & Cosmetics

9:30 am | Developing a New Paradigm For the Skin

Workshop Day

2:30 pm | Panel Discussion: Building a Brand Around the Consumer & Expanding Your Target Population

Elsa Jungman
CEO & Founder
Dr Elsa Jungman

Dr. Elsa Jungman has a Ph.D. in skin delivery and began her career working in R&D for L’Oreal in Paris. In 2015 she moved to San Francisco and worked with several biotech and beauty companies. She learned about the skin microbiome and its importance for skin health by working at AOBiome. Suffering herself from very sensitive skin, she is now the Founder & CEO of Dr Elsa Jungman (ELSI Skin Health), a startup that helps millions of people who struggle with reactive skin by offering clean & personalized skincare with a specific focus on the microbiome. She was awarded in 2019 the French-American Entrepreneurship award. Dr Elsa Jungman (ELSI) is now a resident company of JLABS (J&J Innovation) and the first certified microbiome-friendly brand in the US by MyMicrobiome.

Day One

Thursday 13th December 2018

2:30 pm | Developing a New Platform for Skincare Products

Workshop Day

10:30 am | Positioning the Microbiome to Consumers

2:30 pm | Panel Discussion: Building a Brand Around the Consumer & Expanding Your Target Population

Marie Drago
Founder
Gallinée

Marie Drago is a French Doctor in Pharmacy and a member of the French Society of Cosmetic Science, with over 15 years’ experience working for successful and innovative skincare brands. After discovering how a prebiotic and probiotic diet could improve the symptoms of the gluten intolerance that had been plaguing her life for years, Marie got a Eureka moment: What if we applied the same science to skin? Marie’s thesis on the microbiome and the enormous benefits of harnessing helpful bacteria gave her the vision and the know-how to create Gallinée’s formulations. Thanks to her pharmacy background and her beauty experience, Marie designed formulas like no other, and patented the triple biotic complex that you can now find in Gallinée’s products.

Day One

Thursday 13th December 2018

2:00 pm | Delving into Skin Microbiome Products that Regulate the Scalp

Workshop Day

12:00 pm | Communicating That Bacteria Is Not a Dirty Word - How to Market the Microbiome to Consumers

Kara Bortone
Senior Director, Sourcing & Portfolio Management
Johnson & Johnson Innovation, JLABs

Workshop Day

10:00 am | Harnessing Informed Science to Lever Your Product

Peter Larson
PhD Candidate (Oh Lab)
The Jackson Laboratory for Genomic Medicine

Peter Larson is an MD/PhD Candidate at the University of Connecticut (UCONN). He is currently completing his doctoral research as part of Julia Oh’s group at the Jackson Laboratory for Genomic Medicine. His background is in synthetic biology, which he is currently applying to leverage the human skin microbiome to promote health, prevent infections, and treat diseases. In the Oh lab, he has been engineering Staphylococcus epidermidis, a ubiquitous skin commensal, to detect and kill pathogens, as well as secrete therapeutics. He has also pioneered exploring the use of human skin explants and stem cell derived skin “organoids” to model human skin microbiome interactions in the laboratory. Finally, he has implemented a clinical metagenome study investigating the relationship between aging, health, and the microbiome. These data inform how we can leverage the microbiome to combat chronic illnesses, prevent infections commonly acquired by older adults in healthcare settings, and promote healthy aging.

Day Two

Thursday 13th December 2018

9:00 am | Engineering the Aging Skin Microbiome

Eric Clarke
Senior Business Development Manager
Labskin

Day One

Thursday 13th December 2018

12:00 pm | Artificial Intelligence & Clones – Labskin AI for the Future of Skincare

Cécile Clavaud
Skin Microbiome Projects
L’Oréal

Cécile's initial expertise is chemistry and biochemistry to design new probes for medical imaging (IBISTEC, CEA, Saclay, FRANCE) followed by four years post doc at Institut Pasteur (Paris, FRANCE) to characterize the molecular mechanisms involved in the fungal cell wall polysaccharides biosynthesis. She joined L’Oréal research and Innovation in 2011 to work in an open innovation structure, in charge of establishing partnership with international academic experts. Her main area of interest today is skin and scalp microbiome. Cécile is focusing on the ecology of skin microbiota members (bacteria, fungi and viruses) in various skin physio-pathologies and body sites in order to identify key microbiota changes, key determinants in their interaction with the skin.

Day One

Thursday 13th December 2018

1:30 pm | Understanding How Environmental Pollution Exposure Affects the Microbiome

Greg Maguire
Founder
NeoGenesis

Dr. Greg Maguire, Ph.D. pursued his graduate training at the University of California, Berkeley, University of Houston, University of Texas, The Marine Biological Labs, Woods Hole, MA, and Cold Spring Harbor Laboratory, NY. He is a former professor of neuroscience and ophthalmology at the University of California, San Diego School of Medicine, a visiting associate professor of physiology at Keio University School of Medicine in Tokyo, Japan, visiting assistant professor of molecular neurobiology at the University of Washington, former faculty at the Bascom Palmer Eye Institute, and a visiting scientist at MGH, Harvard University. Awarded a prestigious Fulbright Scholarship from the National Institutes of Health, Dr. Maguire managed his NIH funded laboratory at UCSD studying tissue degeneration and regeneration, and the role of stem cell released molecules (SRM) through paracrine and autocrine actions to maintain, repair, and regenerate human tissues. His NIH funded studies of systems biology and reverse engineering at the University of California, Berkeley and stem cell biology at UCSD led to the development of adult stem cell-based S²RM® technology for the development of therapeutics. Dr. Maguire has over 100 publications, multiple patents, has been elected as a Fellow of the Royal Society of Medicine.

Day Two

Thursday 13th December 2018

10:00 am | Understanding how Prebiotic, Probiotic & Postbiotic Skin Care Can Control Skin & Systemic Inflammation

Paula Simpson
Founder
Nutribloom Consulting

As a founder, innovator and key formulator behind award winning brands, Paula is a sought after speaker and media expert with appearances on: E! News, Entertainment Tonight, Access Hollywood, Good Morning America, Telemundo, MSNBC, KTLA, ABC and FOX NEWS. She’s often cited within and contributes her expertise to leading health & beauty publications including; Allure, Alternative Medicine, Brit+Co, Everyday Health, InStyle, Mindbodygreen, New Beauty Magazine, Rodale’s Organic Life, PopSugar, Reader’s Digest, Refinery 29 and more. Paula is the author of the book “Good Bacteria for Healthy Skin; Nurturing Your Skin Microbiome with Pre- and Probiotics for Clear and Luminous Skin,” published August/September 2019.

Workshop Day

2:30 pm | Panel Discussion: Building a Brand Around the Consumer & Expanding Your Target Population

11:30 am | Informing the Consumer of the Positives of Using Bacteria on the Skin

Maria Cho
COO
Phi Therapeutics

Maria Cho is COO and Co-founder of Phi Therapeutics, Inc. (“Phi”) and is charge of all operations, manufacturing, logistics and quality standards. Maria has an MS in Biomedical chemistry and leverages her 15 years of biologics product development, testing and manufacturing to bring Phi’s first product, the Phyla™ System to market. Prior to joining Phi, Maria was the head of North American sales for Fujifilm’s Biologics manufacturing division and sat on the senior leadership team for operations and prior to Fujifilm worked at WuXi AppTec in various management and business roles.

Day Two

Thursday 13th December 2018

11:45 am | Understanding the Manufacturing Requirements for Cosmetic Products

Nicholas Monsul
Co-Founder
Quorum Innovations

Dr. Monsul completed his medical and surgical training at Yale University School of Medicine and The Johns Hopkins Hospital, where he later remained on faculty. Throughout his career and education as a scientist and clinician he has had a keen interest in translating scientific research into clinically relevant technology. He Co-founded Quorum Innovations as a microbiome therapeutics development company and was recently awarded his ninth patent USPTO patent in the field of microbiome therapeutics.

Day One

Thursday 13th December 2018

4:00 pm | Achieving Barrier Protection: Quorum Biofilm Shield

Day Two

Thursday 13th December 2018

3:30 pm | Panel Discussion - The Borderline Between Therapy & Cosmetics

Eva Berkes
CSO
Quorum Innovations

Dr. Berkes established a private practice in 2002. She is board certified in allergy, asthma and immunology. She graduated from Williams College and attended medical school at the University of Florida, where she remained for her residency in internal medicine. Dr. Berkes completed a fellowship in allergy, asthma and immunology at The Scripps Clinic and Research Institute. Her research focuses on the human microbiome and its relationships with human innate immunity, biofilms and disease states associated with chronic and allergic inflammation. Dr. Berkes is also a co-founder of the Hawthorne Clinic.

Day One

Thursday 13th December 2018

11:30 am | Panel Discussion: Exploring to What Extent Staphylococcus Bacterium are Driving Inflammatory Skin Disease

Larry Weiss
CEO & Founder
Symbiome

Larry Weiss is the CEO and Founder of Symbiome, a San Francisco skin microbiome company. Previously, he was founding Chief Medical Officer at AOBiome where he formulated AOB-101, the first live topical biotherapeutic and ran the first successful virtual Phase IIb clinical trial. He also developed the Mother Dirt cosmetics including AO Mist, the first live skin probiotic. He has an extensive background in natural products chemistry, microbiology, medicine, biophysics, and pharmaceutical and cosmetic product development. He has an MD from Stanford University, and a BS in Biochemistry from Cornell University. He has over 20 patents and is published in the areas of chemistry, electrophysiology, clinical pharmacology, and the microbiome.

Day One

Thursday 13th December 2018

3:30 pm | What We Can Learn About Our Health From the Skin Microbiome of Hunter-Gatherers

Day Two

Thursday 13th December 2018

3:30 pm | Panel Discussion - The Borderline Between Therapy & Cosmetics

Dan Piacuquadio
CEO
Therapeutics Inc.

Dan Piacquadio, M.D. is the founder of Therapeutics Inc. and serves as its President, CEO and CMO. He started Therapeutics as a contract research organization dedicated to the field of dermatology, serving the needs of biotechnology, pharmaceutical and investment communities. His experience in clinical research, medical product development, academia and dermatology practice contribute to his exceptional insight and perspective. Dr. Piacquadio has been active in clinical research and medical product development since 1985, when he was Director of R&D for Oncotherm, a hyperthermia company, and was responsible for regulatory affairs and clinical development. He went on to lead the clinical research program for the Division of Dermatology at the University of California, San Diego and served as Director of this facility from 1989 to 1997, during which it became regarded as one of the leading academic product development groups in the United States. Dr. Piacquadio has been instrumental in the non-clinical and clinical development phases of a variety of soft tissue augmentation products including Hylaform (Biomatrix) and played a key role in defining regulatory strategy and clinical development of the first laser-based hair removal technology pioneered by Thermolase. As a Consultant to the FDA Generic Drug Group, he co-led the development of the current bioequivalency standards for topical steroids. Dr. Piacquadio holds a Bachelor of Science degree in Biomedical Engineering from Rensselaer Polytechnic Institute and his Medical degree from the University of Pennsylvania. He received his graduate clinical training at Brown University as an intern in Internal Medicine and his Dermatology training at the University of California, San Diego.

Day One

Thursday 13th December 2018

10:00 am | Running Dermatology Clinical Trials in the COVID-19 Era

Raja Sivamani
Associate Adjunct Professor, Dermatology
UC Davis

I am a native of the San Francisco Bay Area and a board certified Dermatologist. My expertise centers on general dermatology including medical, surgical, and cosmetic services. With training in bioengineering, Allopathic and Ayurvedic medicine, I take an analytical yet personalized approach to each patient. My research focuses in two areas: sebaceous gland disease and bioengineering adaptations for dermatology. To pursue my research, I integrate concepts from bioengineering, Allopathic medicine, and Ayurvedic medicine. By integrating concepts from Ayurvedic medicine, plant sciences, and food sciences, I look to better understand how we can better integrate nature for individualized medical therapies. By integrating engineering with medicine, I hope we can develop and deliver care in innovative and effective ways.

Day Two

Thursday 13th December 2018

3:00 pm | The Skin & Gut Microbiome & It’s Role in Common Dermatological Conditions

Huiying Li
Assistant Professor
UCLA

Dr. Huiying Li is an Associate Professor in the Department of Molecular and Medical Pharmacology at UCLA School of Medicine. Her research group investigates the role of the skin microbiome in health and disease, including two most common skin diseases, acne vulgaris and atopic dermatitis. By combining high-throughput technologies, bioinformatics, microbiology, and biochemistry, Dr. Li and her group analyze the genomes, metagenomes, metatranscriptomes, and metabolomes of the microorganisms in the human microbiome and their interactions with the host. The findings from these studies can potentially lead to new diagnostics and interventions.

Day One

Thursday 13th December 2018

11:30 am | Panel Discussion: Exploring to What Extent Staphylococcus Bacterium are Driving Inflammatory Skin Disease

9:00 am | Understanding Skin Microbiome Differences in Strains and Over Ages

Mingxun Wang
Postdoctoral Researcher
UCSD

Day One

Thursday 13th December 2018

12:10 pm | Applying Computational Techniques in Skin Analysis: Repository Scale Data & Biological/Chemical Insights

Matthew Bresnahan
Partner
Wilson Sonsini Goodrich & Rosati

Day Two

Thursday 13th December 2018

12:45 pm | Achieving Intellectual Property on a Product That Modulates the Skin Microbiome

Momo Vuysich
CSO
Viome

Day Two

Thursday 13th December 2018

2:30 pm | Understanding the Key to Healthy Skin Is In the Gut

Natalise Kalea Robinson
Founder & CEO
Parallel

Workshop Day

1:30 pm | Building a Breakthrough Microbiome Brand